COMPARATIVE EFFICACY Of TARLATAMAB And SECOND-LINE THERAPIES in EXTENSIVE-STAGE SMALL CELL LUNG CANCER : A NETWORK Meta-Analysis . ( SCIENCE DIRECT ) .